Purpose of the Test
- Identify the presence of the V600E mutation in the BRAF gene.
- Assist oncologists in selecting the most effective targeted therapy.
- Evaluate the patient's potential response to BRAF and MEK inhibitors.
Book BRAF Mutation Test in Saudi Arabia | Lahalak Medical Platform
This molecular test is a critical step in determining the optimal treatment plan for cancer patients, helping select targeted therapies that address genetic mutations with high precision to improve outcomes.
Scientific name: BRAF Mutation Analysis for Oncology
An advanced molecular test to detect BRAF gene mutations (specifically V600E) in tumor samples. It guides oncologists in selecting targeted therapies and MEK inhibitors for melanoma and colorectal cancer treatments.
Service type
Molecular analysis
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Sample collection
- Genetic sequencing analysis
- Detailed laboratory report
Medical Service Information
Target Groups
- Patients diagnosed with Melanoma.
- Patients with Colorectal Cancer.
- Advanced cases of Thyroid Cancer.
Clinical Significance
- Enables personalized medicine by tailoring treatment to the tumor's genetic profile.
- Avoids the use of ineffective conventional chemotherapy in specific genetic contexts.
Conditions & Notices
- Provide previous medical reports
- Pre-coordination for sample type (blood or tissue)
Medical services you might also like
